# Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo

> **NCT01890538** · PHASE4 · COMPLETED · sponsor: **Kocaeli University** · enrollment: 94 (actual)

## Conditions studied

- Peripheral Vertigo

## Interventions

- **DRUG:** Administration of 100 mg dimenhydrinate intravenous
- **DRUG:** 2 g piracetam intravenous

## Key facts

- **NCT ID:** NCT01890538
- **Lead sponsor:** Kocaeli University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2014-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890538, "Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT01890538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*